Total Payments
$14,085
2024 Payments
$1,724
Companies
43
Transactions
420
Medicare Patients
11,609
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$12,190 (86.6%)
Other$1,350 (9.6%)
Education$544.32 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,190 | 408 | 86.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,000 | 1 | 7.1% |
| Education | $544.32 | 10 | 3.9% |
| Honoraria | $350.00 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $3,471 | 18 | $0 (2023) |
| Biofrontera Inc. | $1,691 | 11 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $851.76 | 47 | $0 (2024) |
| Lilly USA, LLC | $798.79 | 33 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $633.28 | 23 | $0 (2023) |
| ABBVIE INC. | $606.28 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $581.22 | 18 | $0 (2024) |
| GENZYME CORPORATION | $536.39 | 22 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $492.77 | 22 | $0 (2024) |
| Hill Dermaceuticals, Inc. | $440.74 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,724 | 71 | UCB, Inc. ($252.28) |
| 2023 | $1,822 | 64 | Merz North America, Inc. ($200.00) |
| 2022 | $1,569 | 56 | Merz North America, Inc. ($399.22) |
| 2021 | $801.48 | 35 | VYNE Pharmaceuticals Inc. ($177.55) |
| 2020 | $864.92 | 36 | MERZ NORTH AMERICA, INC. ($145.52) |
| 2019 | $4,219 | 77 | Merz North America, Inc. ($1,827) |
| 2018 | $2,338 | 49 | Merz North America, Inc. ($854.74) |
| 2017 | $746.53 | 32 | Exeltis, USA Inc. ($116.43) |
All Payment Transactions
420 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $33.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.27 | General |
| 09/04/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Immunology | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: Immunology | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 07/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $80.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.53 | General |
| Category: Immunology | ||||||
| 07/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $44.97 | General |
| Category: Immunology | ||||||
| 07/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,721 | 5,518 | $813,714 | $268,841 |
| 2022 | 24 | 2,777 | 5,321 | $802,224 | $264,872 |
| 2021 | 25 | 2,509 | 5,058 | $733,588 | $249,167 |
| 2020 | 32 | 3,602 | 9,972 | $972,922 | $328,903 |
Total Patients
11,609
Total Services
25,869
Medicare Billing
$1.1M
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 366 | 516 | $130,955 | $45,166 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 455 | 595 | $106,585 | $35,342 | 33.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 75 | 86 | $80,800 | $31,404 | 38.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 314 | 391 | $77,837 | $26,988 | 34.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 453 | 641 | $84,870 | $24,762 | 29.2% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 64 | 71 | $60,003 | $23,318 | 38.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 339 | 2,489 | $32,060 | $12,284 | 38.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 78 | 95 | $31,676 | $11,218 | 35.4% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 34 | 34 | $26,832 | $10,250 | 38.2% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 52 | 57 | $30,353 | $6,200 | 20.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $16,964 | $5,321 | 31.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 49 | 50 | $24,251 | $4,811 | 19.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 54 | 60 | $13,351 | $4,736 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 65 | 65 | $14,546 | $4,155 | 28.6% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 41 | 42 | $21,050 | $4,129 | 19.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 79 | 99 | $9,791 | $3,850 | 39.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 32 | 33 | $18,375 | $3,686 | 20.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 25 | 33 | $11,659 | $3,595 | 30.8% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 11 | 11 | $8,513 | $3,306 | 38.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 23 | 23 | $5,678 | $2,178 | 38.4% |
| 69100 | Biopsy of ear | Office | 2023 | 26 | 27 | $5,157 | $1,214 | 23.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 21 | $2,348 | $904.83 | 38.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 28 | $60.71 | $23.85 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 358 | 467 | $119,524 | $40,517 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 471 | 644 | $117,079 | $39,171 | 33.5% |
About Dr. Frank Armstrong, DO
Dr. Frank Armstrong, DO is a Dermatology healthcare provider based in Seminole, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952390148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Armstrong, DO has received a total of $14,085 in payments from pharmaceutical and medical device companies, with $1,724 received in 2024. These payments were reported across 420 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($12,190).
As a Medicare-enrolled provider, Armstrong has provided services to 11,609 Medicare beneficiaries, totaling 25,869 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Seminole, FL
- Active Since 10/19/2005
- Last Updated 10/12/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1952390148
Products in Payments
- Ameluz (Drug) $1,552
- XEOMIN (Biological) $1,042
- DUPIXENT (Biological) $1,027
- TALTZ (Drug) $670.21
- Xeomin (Biological) $599.22
- COSENTYX (Biological) $505.03
- Tolak (Drug) $419.38
- SILIQ (Drug) $327.35
- SKYRIZI (Biological) $323.01
- COSENTYX (Drug) $307.10
- Bimzelx (Biological) $284.69
- EUCRISA (Drug) $246.40
- AMZEEQ (Drug) $245.10
- ILUMYA (Biological) $234.29
- DUOBRII (Drug) $226.59
- Otezla (Drug) $208.45
- ADBRY (Biological) $171.42
- RHOFADE (Drug) $166.31
- Impoyz (Drug) $159.87
- Skyrizi (Biological) $144.39
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.